{"id":"https://openalex.org/W2002142985","doi":"https://doi.org/10.1517/13543776.2013.770840","title":"AMPA receptor positive allosteric modulators: a patent review","display_name":"AMPA receptor positive allosteric modulators: a patent review","alternate_titles":[],"publication_year":2013,"publication_date":"2013-02-13","ids":{"openalex":"https://openalex.org/W2002142985","doi":"https://doi.org/10.1517/13543776.2013.770840","mag":"2002142985","pmid":"https://pubmed.ncbi.nlm.nih.gov/23405869"},"language":"en","primary_location":{"id":"doi:10.1517/13543776.2013.770840","doi":"https://doi.org/10.1517/13543776.2013.770840","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543776.2013.770840","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002142985"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087763748","display_name":"Bernard Pirotte","orcid":"https://orcid.org/0000-0001-8251-8257","observed_orcids":["https://orcid.org/0000-0001-8251-8257"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard Pirotte","raw_affiliation_strings":["University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, Li\u00e8ge, Belgium. b.pirotte@ulg.ac.be","Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, Li\u00e8ge, Belgium. b.pirotte@ulg.ac.be","institution_ids":["https://openalex.org/I157674565"]},{"raw_affiliation_string":"Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089527515","display_name":"Pierre Francotte","orcid":"https://orcid.org/0000-0001-9252-7798","observed_orcids":["https://orcid.org/0000-0001-9252-7798"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierre Francotte","raw_affiliation_strings":["University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, 1, Avenue de l'H\u00f4pital, B-4000 Li\u00e8ge, Belgium","Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, 1, Avenue de l'H\u00f4pital, B-4000 Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]},{"raw_affiliation_string":"Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010472156","display_name":"Eric Goffin","orcid":"https://orcid.org/0000-0002-3868-9494","observed_orcids":["https://orcid.org/0000-0002-3868-9494"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric Goffin","raw_affiliation_strings":["University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, 1, Avenue de l'H\u00f4pital, B-4000 Li\u00e8ge, Belgium","Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, 1, Avenue de l'H\u00f4pital, B-4000 Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]},{"raw_affiliation_string":"Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103078517","display_name":"Pascal De Tullio","orcid":"https://orcid.org/0000-0003-1416-3858","observed_orcids":["https://orcid.org/0000-0003-1416-3858"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pascal de Tullio","raw_affiliation_strings":["University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, 1, Avenue de l'H\u00f4pital, B-4000 Li\u00e8ge, Belgium","Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Liege, Drug Research Center (CIRM), Department of Medicinal Chemistry, 1, Avenue de l'H\u00f4pital, B-4000 Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]},{"raw_affiliation_string":"Universit\u00e9 de Li\u00e8ge - ULg > D\u00e9partement de pharmacie > Chimie pharmaceutique >  >","institution_ids":["https://openalex.org/I157674565"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I157674565"],"apc_list":null,"apc_paid":null,"fwci":0.4678,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.36319218,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"23","issue":"5","first_page":"615","last_page":"628"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ampa-receptors","display_name":"AMPA receptors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/positive-allosteric-modulators","display_name":"positive allosteric modulators","score":0.9980000257492065},{"id":"https://openalex.org/keywords/patent-literature","display_name":"patent literature","score":0.5199999809265137},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.49399998784065247},{"id":"https://openalex.org/keywords/bdnf-expression","display_name":"BDNF expression","score":0.7260000109672546},{"id":"https://openalex.org/keywords/neurological-disorders","display_name":"neurological disorders","score":0.652999997138977},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8690000176429749},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6779999732971191},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8510000109672546},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9869999885559082},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7870000004768372},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.8658500909805298},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.6672061085700989},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6228371262550354},{"id":"https://openalex.org/C2776038425","wikidata":"https://www.wikidata.org/wiki/Q2649417","display_name":"Allosteric modulator","level":4,"score":0.5140015482902527},{"id":"https://openalex.org/C115955781","wikidata":"https://www.wikidata.org/wiki/Q6063798","display_name":"Ionotropic effect","level":4,"score":0.498995304107666},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45034852623939514},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.39434242248535156},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3716990351676941},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.32899200916290283},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32321423292160034},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0704902708530426}],"mesh":[{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1517/13543776.2013.770840","doi":"https://doi.org/10.1517/13543776.2013.770840","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543776.2013.770840","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},{"id":"pmid:23405869","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23405869","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic patents","raw_type":"Journal Article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/148168","doi":null,"is_oa":false,"landing_page_url":"https://orbi.uliege.be/handle/2268/148168","pdf_url":null,"source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Therapeutic Patents, 23, 615-628 (2013)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":69,"referenced_works":["https://openalex.org/W78616893","https://openalex.org/W96311491","https://openalex.org/W179376908","https://openalex.org/W594734102","https://openalex.org/W1033881574","https://openalex.org/W1545262703","https://openalex.org/W1636225847","https://openalex.org/W1780394705","https://openalex.org/W1848210821","https://openalex.org/W1922786159","https://openalex.org/W1967545898","https://openalex.org/W1968097213","https://openalex.org/W1972146039","https://openalex.org/W1974071870","https://openalex.org/W1978817835","https://openalex.org/W1980413249","https://openalex.org/W1987702456","https://openalex.org/W1991626940","https://openalex.org/W1995394897","https://openalex.org/W1997808826","https://openalex.org/W2003618648","https://openalex.org/W2008283517","https://openalex.org/W2013076099","https://openalex.org/W2015118408","https://openalex.org/W2020073744","https://openalex.org/W2022116685","https://openalex.org/W2022279290","https://openalex.org/W2025525831","https://openalex.org/W2030448540","https://openalex.org/W2030993564","https://openalex.org/W2033307823","https://openalex.org/W2035458333","https://openalex.org/W2037223939","https://openalex.org/W2037835075","https://openalex.org/W2043835597","https://openalex.org/W2044208012","https://openalex.org/W2051942403","https://openalex.org/W2053847230","https://openalex.org/W2059455276","https://openalex.org/W2061334380","https://openalex.org/W2062856075","https://openalex.org/W2064455174","https://openalex.org/W2065005660","https://openalex.org/W2065521724","https://openalex.org/W2069644503","https://openalex.org/W2072368655","https://openalex.org/W2074907255","https://openalex.org/W2078579713","https://openalex.org/W2079302576","https://openalex.org/W2100212334","https://openalex.org/W2106962648","https://openalex.org/W2112882116","https://openalex.org/W2116031189","https://openalex.org/W2128904157","https://openalex.org/W2137924693","https://openalex.org/W2144237113","https://openalex.org/W2147542138","https://openalex.org/W2153145185","https://openalex.org/W2156919111","https://openalex.org/W2163851282","https://openalex.org/W2203766835","https://openalex.org/W2256726180","https://openalex.org/W2285714527","https://openalex.org/W2328088698","https://openalex.org/W2395331031","https://openalex.org/W2750713714","https://openalex.org/W2784566176","https://openalex.org/W2852682993","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2496696200","https://openalex.org/W2043835597","https://openalex.org/W7100037929","https://openalex.org/W2055023244","https://openalex.org/W2054619640","https://openalex.org/W7214930646","https://openalex.org/W179376908","https://openalex.org/W7221688344","https://openalex.org/W1966952342","https://openalex.org/W2044997440"],"abstract_inverted_index":{"INTRODUCTION:":[0],"AMPA":[1,38,65,98],"receptors":[2],"represent":[3],"an":[4,119,132],"interesting":[5,161],"target":[6],"to":[7,22,42,62,71,109,117,145,148],"develop":[8],"innovative":[9],"therapeutic":[10,165],"drugs":[11],"such":[12,52,141],"as":[13,53,78],"positive":[14,67],"allosteric":[15,68],"modulators,":[16],"a":[17,157],"subclass":[18],"of":[19,26,31,37,48,75,86,96,152],"modulators":[20,69,100],"known":[21],"potentiate":[23],"the":[24,46,73,81,84,104,150,153],"effect":[25],"glutamate":[27],"through":[28],"this":[29],"kind":[30],"glutamatergic":[32],"ionotropic":[33],"receptors.":[34],"The":[35,136],"enhancement":[36],"signals":[39],"is":[40,116],"expected":[41],"be":[43,72,146],"beneficial":[44],"in":[45,83,103,125,163],"management":[47],"several":[49],"neurological":[50],"disorders,":[51],"depression,":[54],"schizophrenia,":[55],"Parkinson's":[56],"disease":[57],"and":[58],"learning-memory":[59],"deficits":[60],"linked":[61],"Alzheimer's":[63],"disease.":[64],"receptor":[66,99],"continue":[70],"object":[74],"intensive":[76],"research":[77],"evidenced":[79],"by":[80],"diversification":[82],"range":[85],"chemotypes":[87],"explored.":[88],"AREAS":[89],"COVERED:":[90],"This":[91],"article":[92],"examines":[93],"recent":[94],"discoveries":[95],"new":[97,164],"mainly":[101],"described":[102],"patent":[105],"literature":[106],"from":[107],"2008":[108],"2012.":[110],"EXPERT":[111],"OPINION:":[112],"An":[113],"important":[114],"challenge":[115],"discover":[118],"ideal":[120],"drug":[121],"candidate":[122],"exhibiting":[123],"appropriate":[124],"vivo":[126],"activity":[127],"after":[128],"oral":[129],"administration":[130],"with":[131],"acceptable":[133],"safety":[134],"profile.":[135],"future":[137],"remains":[138],"promising":[139],"because":[140],"compounds":[142],"have":[143],"proved":[144],"able":[147],"stimulate":[149],"expression":[151],"neurotrophic":[154],"factor":[155],"BDNF,":[156],"unique":[158],"property":[159],"opening":[160],"perspectives":[162],"applications.":[166]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002142985","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
